Skip to Content
Merck
  • Design, synthesis and evaluation of 2,4-disubstituted pyrimidines as cholinesterase inhibitors.

Design, synthesis and evaluation of 2,4-disubstituted pyrimidines as cholinesterase inhibitors.

Bioorganic & medicinal chemistry letters (2010-05-18)
Tarek Mohamed, Praveen P N Rao
ABSTRACT

A group of 2,4-disubstituted pyrimidine derivatives (7a-e, 8a-e and 9a-d) that possess a variety of C-2 aliphatic five- and six-membered heterocycloalkyl ring in conjunction with a C-4 arylalkylamino substituent were designed, synthesized and evaluated as cholinesterase (ChE) inhibitors. The steric and electronic properties at C-2 and C-4 positions of the pyrimidine ring were varied to investigate their effect on ChE inhibitory potency and selectivity. The structure-activity relationship (SAR) studies identified N-benzyl-2-thiomorpholinopyrimidin-4-amine (7c) as the most potent cholinesterase inhibitor (ChEI) with an IC(50)=0.33 microM (acetylcholinesterase, AChE) and 2.30muM (butyrylcholinesterase, BuChE). The molecular modeling studies indicate that within the AChE active site, the C-2 thiomorpholine substituent was oriented toward the cationic active site region (Trp84 and Phe330) whereas within the BuChE active site, it was oriented toward a hydrophobic region closer to the active site gorge entrance (Ala277). Accordingly, steric and electronic properties at the C-2 position of the pyrimidine ring play a critical role in ChE inhibition.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Butyrylcholinesterase from equine serum, lyophilized powder, ≥900 units/mg protein
Sigma-Aldrich
Acetylcholinesterase from Electrophorus electricus (electric eel), Type VI-S, lyophilized powder, 200-1,000 units/mg protein